Finding a clinical trial for a cancer patient demands extraordinary effort as it requires evaluating many available trial opportunities against specific patient characteristics. Ancora.ai accelerates clinical trial recruitment by systematically and seamlessly connecting patients to trials. Our proprietary technology structures jargon-laden clinical trial protocols into an easy to use interface to match any patient to trials at scale. Our best-in-class trial matching solution means we can more efficiently and effectively match highly qualified patients to the right trials, thereby transforming the $44B. clinical research industry to be data-driven & enabling precision medicine recruitment.
23.01.2024
Ancora.ai: The Venture Leader Mobile employing patient-first approach to democratize clinical trial access (venturelab.swiss)
22.01.2024
The Venture Leaders Mobile 2024 kick-off their roadshow to the Mobile World Congress in Barcelona (venturelab.swiss)
14.12.2023
Ten startups join the 2024 roadshow in Barcelona (startupticker.ch)
26.09.2023
Future of Health Grant kicks off with new cohort (startupticker.ch)
01.07.2023
Achieved First Top 10 Pharma Contract
31.10.2022
Neuroendocrine Tumor Trial Finder Funding
01.10.2021
Preseed Round
No Jobs
No videos and documents
The Venture Leaders - as members of the Swiss National Startup Team - have a clear-cut goal. They envision themselves as global players and want to take the first step to their global expansion. The Venture Leaders’ startup development program is specifically structured to help them achieve these goals. Each year, the Venture Leaders Mobile journey offers selected entrepreneurs an accelerated learning curve and a solid network through their participation at the Mobile World Congress and 4YFN Conference.
Website:
www.ancora.ai/
Headquarter:
Zurich
Foundation Date:
June 2020
Technology:
Sectors: